Showing results (131-140 of 3,342) with videos related to
Sort By:
Pageof 335
CNS Oncology|July 12, 2023
Long-term survival after salvage pemetrexed for refractory primary T-cell lymphoma of the CNSAndy Liu, Huda Alalami, Xuemo Fan, et al.Clinical Reviews in Allergy & Immunology|February 20, 2021
A Review of Persistent Post-COVID Syndrome (PPCS)Bryan Oronsky, Christopher Larson, Terese C Hammond, et al.Journal of Translational Medicine|October 20, 2017
A novel small molecule inhibitor of p32 mitochondrial protein overexpressed in gliomaVenkata Yenugonda, Natsuko Nomura, Valentina Kouznetsova, et al.Journal of Neuro-Oncology|October 29, 2013
PTEN status mediates 2ME2 anti-tumor efficacy in preclinical glioblastoma models: role of HIF1α suppressionCarrie R Muh, Shweta Joshi, Alok R Singh, et al.Nuclear Medicine Communications|February 26, 2015
Glucose-corrected standardized uptake value in the differentiation of high-grade glioma versus post-treatment changesAsae Nozawa, Ali Hosseini Rivandi, Masayuki Kanematsu, et al.Case Reports in Oncology|April 3, 2023
Case Report of AdAPT-001-Mediated Sensitization to a Previously Failed Checkpoint Inhibitor in a Metastatic Chordoma PatientSantosh Kesari, Jeannie Williams, Erica Burbano, et al.Annals of Translational Medicine|May 21, 2015
Hyaluronan expression in primary and secondary brain tumorsLaurence Jadin, Sandra Pastorino, Rebecca Symons, et al.Frontiers in Oncology|September 8, 2022
Safety of Tumor Treating Fields (TTFields) therapy in pediatric patients with malignant brain tumors: Post-marketing surveillance dataStewart Goldman, Ashley Margol, Eugene I Hwang, et al.Human Antibodies|September 19, 2018
Antibody drug conjugates: Progress, pitfalls, and promisesAnubhab Mukherjee, Ariana K Waters, Ivan Babic, et al.Endocrine Research|April 13, 2018
Diagnostic evaluation in steroid-induced myopathy: case report suggesting clinical utility of quantitative muscle ultrasonographyMarco Alessandro Minetto, Cristina Caresio, Valentina D'Angelo, et al.Pageof 335